Free tool
Heavily traded stocks
We cover 541 companies whose typical session turns over more than $10.00M. The median market value in the group is $1.39B. Across the group, the median move over the past trading day is −0.33%. 60% of the 533 with a 200-day average trade above it. Price change over the past year runs from −36.0% to +179.7% across the middle 80 percent of the group, with a median of +9.3%. Across the group, 6 companies currently carry a tier A volume signal.
Other lists in this group
Table
541 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| PODD | Insulet Corporation | $9.94B | Mid cap | −57.12% |
| AVTR | Avantor, Inc. | $9.81B | Mid cap | +9.93% |
| PTGX | Protagonist Therapeutics, Inc. | $9.80B | Mid cap | +146.62% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +62.83% |
| OSCR | Oscar Health, Inc. | $9.55B | Mid cap | +83.55% |
| TWST | Twist Bioscience Corporation | $9.41B | Mid cap | +451.89% |
| DEMANT.CO | Demant A/S | $9.36B | Mid cap | +17.12% |
| PCVX | Vaxcyte, Inc. | $9.09B | Mid cap | +99.97% |
| IMVT | Immunovant, Inc. | $9.07B | Mid cap | +189.13% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −9.65% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −6.73% |
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% |
| BRKR | Bruker Corporation | $8.69B | Mid cap | +70.56% |
| ATR | AptarGroup, Inc. | $8.60B | Mid cap | −1.89% |
| 4151.T | Kyowa Kirin Co., Ltd. | $8.51B | Mid cap | +4.01% |
| 4523.T | Eisai Co., Ltd. | $8.48B | Mid cap | +7.64% |
| TGTX | TG Therapeutics, Inc. Common Stock | $8.42B | Mid cap | +92.61% |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% |
| RHC.AX | Ramsay Health Care Limited | $8.27B | Mid cap | +50.11% |
| ALKS | Alkermes plc | $8.25B | Mid cap | +68.07% |
| SYRE | Spyre Therapeutics, Inc. | $8.13B | Mid cap | +446.12% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +9.35% |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% |
| 2413.T | M3, Inc. | $7.53B | Mid cap | −17.22% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +54.43% |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +74.18% |
| 6869.T | Sysmex Corporation | $7.28B | Mid cap | +3.66% |
| ALK-B.CO | ALK-Abelló A/S | $7.26B | Mid cap | +5.09% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +56.66% |
| SHL.AX | Sonic Healthcare Limited | $7.14B | Mid cap | −11.84% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% |
| PACS | PACS Group, Inc. | $7.03B | Mid cap | +274.28% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% |
| HIMS | Hims & Hers Health, Inc. | $6.96B | Mid cap | −32.22% |
| CGON | CG Oncology, Inc. | $6.95B | Mid cap | +196.15% |
| 3391.T | Tsuruha Holdings Inc. | $6.89B | Mid cap | +5.97% |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | $6.82B | Mid cap | +15.35% |
| ERAS | Erasca, Inc. | $6.70B | Mid cap | +1112.03% |
| 7747.T | Asahi Intecc Co., Ltd. | $6.68B | Mid cap | +53.99% |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +77.38% |
| ORKA | Oruka Therapeutics, Inc. | $6.58B | Mid cap | +555.07% |
| RADL3.SA | Raia Drogasil S.A. | $6.56B | Mid cap | +7.42% |
| HLUN-B.CO | H. Lundbeck A/S | $6.47B | Mid cap | +8.99% |
| 3088.T | MatsukiyoCocokara & Co. | $6.45B | Mid cap | −14.74% |
| COH.AX | Cochlear Limited | $6.39B | Mid cap | −53.79% |
| COGT | Cogent Biosciences, Inc. | $6.39B | Mid cap | +196.85% |
| BLTE | Belite Bio, Inc | $6.31B | Mid cap | +144.07% |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +154.86% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +143.24% |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.27B | Mid cap | +92.20% |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% |
| XENE | Xenon Pharmaceuticals Inc. | $6.18B | Mid cap | +64.11% |
| DNTH | Dianthus Therapeutics, Inc. | $6.13B | Mid cap | +356.93% |
| PTCT | PTC Therapeutics, Inc. Common Stock | $6.07B | Mid cap | +46.02% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.05B | Mid cap | +133.47% |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +7.27% |
| CTEC.L | Convatec Group PLC | $6.01B | Mid cap | −1.95% |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +31.96% |
| DFTX | Definium Therapeutics, Inc. | $5.88B | Mid cap | +344.37% |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% |
| LGND | Ligand Pharmaceuticals Incorporated | $5.74B | Mid cap | +80.92% |
| CRSP | CRISPR Therapeutics AG | $5.73B | Mid cap | +10.65% |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% |
| SHC | Sotera Health Company | $5.58B | Mid cap | +18.42% |
| MMED | MiniMed Group, Inc. | $5.48B | Mid cap | +5.41% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | −0.28% |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.07B | Mid cap | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +93.26% |
| 326030.KS | SK Biopharmaceuticals Co., Ltd. | $4.89B | Mid cap | −11.24% |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% |
| EWTX | Edgewise Therapeutics, Inc. | $4.80B | Mid cap | +207.13% |
| LFST | LifeStance Health Group, Inc. | $4.69B | Mid cap | +121.31% |
| CELC | Celcuity Inc. | $4.65B | Mid cap | +90.31% |
| WAY | Waystar Holding Corp. | $4.63B | Mid cap | −34.97% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | $4.63B | Mid cap | +66.34% |
| HIK.L | Hikma Pharmaceuticals PLC | $4.61B | Mid cap | −9.62% |
| BLLN | BillionToOne, Inc. | $4.54B | Mid cap | −11.68% |
| 000100.KS | Yuhan Corporation | $4.50B | Mid cap | −27.54% |
| ICUI | ICU Medical, Inc. | $4.49B | Mid cap | +41.83% |
| NVST | Envista Holdings Corporation | $4.47B | Mid cap | +30.89% |
| ELVN | Enliven Therapeutics, Inc. | $4.46B | Mid cap | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% |
| DOCS | Doximity, Inc. | $4.41B | Mid cap | −63.61% |
| LIVN | LivaNova PLC | $4.41B | Mid cap | +41.56% |
| MANE | Veradermics, Incorporated | $4.29B | Mid cap | +172.32% |
| TNGX | Tango Therapeutics, Inc. | $4.29B | Mid cap | +269.13% |
| RLAY | Relay Therapeutics, Inc. | $4.26B | Mid cap | +445.10% |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% |
| INDV | Indivior Pharmaceuticals, Inc. | $4.23B | Mid cap | +47.06% |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% |
| ANN.AX | Ansell Limited | $4.17B | Mid cap | +18.41% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% |
| IRTC | iRhythm Holdings, Inc. | $4.06B | Mid cap | −29.83% |
| 4506.T | Sumitomo Pharma Co., Ltd. | $4.05B | Mid cap | −3.59% |
| LEGN | Legend Biotech Corporation | $4.02B | Mid cap | −40.44% |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% |
| VKTX | Viking Therapeutics, Inc. | $4.01B | Mid cap | +29.15% |
| DNLI | Denali Therapeutics Inc. | $3.98B | Mid cap | +57.50% |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +55.97% |
| MCOV-B.ST | Medicover AB (publ) | $3.85B | Mid cap | −8.20% |
| 000105.KS | Yuhan Corporation | $3.84B | Mid cap | −32.04% |
| TLX.AX | Telix Pharmaceuticals Limited | $3.82B | Mid cap | +4.88% |
| CAMX.ST | Camurus AB (publ) | $3.79B | Mid cap | −15.35% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | $3.74B | Mid cap | +21.45% |
| 7459.T | MediPal Holdings Corporation | $3.72B | Mid cap | +13.38% |
| IOVA | Iovance Biotherapeutics, Inc. | $3.66B | Mid cap | +233.88% |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% |
| OPCH | Option Care Health, Inc. | $3.60B | Mid cap | −15.91% |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +54.81% |
| GPCR | Structure Therapeutics Inc. | $3.56B | Mid cap | +159.74% |
| GRAL | GRAIL, Inc. | $3.55B | Mid cap | +136.66% |
| QURE | uniQure N.V. | $3.53B | Mid cap | +223.49% |
| NHC | National HealthCare Corporation | $3.53B | Mid cap | +103.83% |
| PLSE | Pulse Biosciences, Inc. | $3.43B | Mid cap | +203.47% |
| ZEAL.CO | Zealand Pharma A/S | $3.34B | Mid cap | −25.94% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +188.94% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.30B | Mid cap | +281.97% |
| NAMS | NewAmsterdam Pharma Company N.V. | $3.27B | Mid cap | +11.97% |
| 3349.T | COSMOS Pharmaceutical Corporation | $3.26B | Mid cap | −26.59% |
| MBX | MBX Biosciences, Inc. | $3.22B | Mid cap | +366.53% |
| BEAM | Beam Therapeutics Inc. | $3.21B | Mid cap | +79.06% |
| TMDX | TransMedics Group, Inc. | $3.19B | Mid cap | −21.43% |
| CLDX | Celldex Therapeutics, Inc. | $3.19B | Mid cap | +79.51% |
| IRON | Disc Medicine, Inc. | $3.17B | Mid cap | +37.90% |
| WRBY | Warby Parker Inc. | $3.15B | Mid cap | −3.96% |
| 7649.T | Sugi Holdings Co.,Ltd. | $3.13B | Mid cap | −28.60% |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.12B | Mid cap | +60.64% |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.10B | Mid cap | +22.19% |
| ALMS | Alumis Inc. | $3.06B | Mid cap | +380.08% |
| BIOA-B.ST | BioArctic AB (publ) | $3.00B | Mid cap | +12.31% |
| ASKER.ST | Asker Healthcare Group AB (publ) | $2.99B | Mid cap | −24.65% |
| HYPE3.SA | Hypera S.A. | $2.98B | Mid cap | −4.69% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% |
| ZLAB | Zai Lab Limited | $2.92B | Mid cap | −20.06% |
| BKD | Brookdale Senior Living Inc. | $2.91B | Mid cap | +55.61% |
| ALHC | Alignment Healthcare, Inc. | $2.88B | Mid cap | −13.88% |
| ACHC | Acadia Healthcare Company, Inc. | $2.85B | Mid cap | +37.81% |
| SLS | SELLAS Life Sciences Group, Inc. | $2.77B | Mid cap | +615.10% |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% |
| 9989.T | Sundrug Co.,Ltd. | $2.76B | Mid cap | −17.34% |
| VRDN | Viridian Therapeutics, Inc. | $2.75B | Mid cap | +30.71% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% |
| PRVA | Privia Health Group, Inc. | $2.71B | Mid cap | −3.13% |
| AMBU-B.CO | Ambu A/S | $2.69B | Mid cap | −19.13% |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | −30.11% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% |
| VERA | Vera Therapeutics, Inc. | $2.65B | Mid cap | +67.21% |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +61.66% |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.61B | Mid cap | −0.42% |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.61B | Mid cap | −12.10% |
| PHVS | Pharvaris N.V. | $2.60B | Mid cap | +55.59% |
| BHVN | Biohaven Ltd. | $2.56B | Mid cap | +8.65% |
| TRVI | Trevi Therapeutics, Inc. | $2.55B | Mid cap | +124.00% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% |
| 2784.T | Alfresa Holdings Corporation | $2.53B | Mid cap | +6.80% |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% |
| NKTR | Nektar Therapeutics | $2.52B | Mid cap | +151.95% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.51B | Mid cap | +15.38% |
| BAVA.CO | Bavarian Nordic A/S | $2.51B | Mid cap | −7.97% |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +321.09% |
| PBH | Prestige Consumer Healthcare Inc. | $2.47B | Mid cap | −22.12% |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% |
| NUVB | Nuvation Bio Inc. | $2.44B | Mid cap | +135.93% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.44B | Mid cap | +5.23% |
| BHC | Bausch Health Companies Inc. | $2.43B | Mid cap | −10.45% |
| ONT.L | Oxford Nanopore Technologies plc | $2.41B | Mid cap | −2.24% |
| OCUL | Ocular Therapeutix, Inc. | $2.37B | Mid cap | −12.58% |
| GRDN | Guardian Pharmacy Services, Inc. | $2.36B | Mid cap | +45.50% |
| 009420.KS | Hanall Biopharma Co., Ltd. | $2.36B | Mid cap | +112.62% |
| UFPT | UFP Technologies, Inc. | $2.36B | Mid cap | +41.94% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% |
| BFLY | Butterfly Network, Inc. | $2.30B | Mid cap | +450.32% |
| COAG | Hemab Therapeutics Holdings, Inc. | $2.30B | Mid cap | +44.68% |
| MLYS | Mineralys Therapeutics, Inc. | $2.28B | Mid cap | +70.22% |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% |
| CLOV | Clover Health Investments, Corp. | $2.26B | Mid cap | +57.99% |
| ADUS | Addus HomeCare Corporation | $2.25B | Mid cap | +4.50% |
| URGN | UroGen Pharma Ltd. | $2.25B | Mid cap | +135.11% |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.20B | Mid cap | +36.58% |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +56.87% |
| 302440.KS | SK bioscience Co.,Ltd. | $2.18B | Mid cap | −20.29% |
| XRAY | DENTSPLY SIRONA Inc. | $2.18B | Mid cap | −21.61% |
| EXE.TO | Extendicare Inc. | $2.18B | Mid cap | +146.56% |
| VCEL | Vericel Corporation | $2.17B | Mid cap | +18.25% |
| 9987.T | Suzuken Co., Ltd. | $2.17B | Mid cap | −12.93% |
| ADMA | ADMA Biologics, Inc. | $2.16B | Mid cap | −44.17% |
| ZBIO | Zenas BioPharma, Inc. | $2.15B | Mid cap | +97.73% |
| ESTA | Establishment Labs Holdings Inc. | $2.15B | Mid cap | +70.71% |
| STOK | Stoke Therapeutics, Inc. | $2.14B | Mid cap | +71.45% |
| GN.CO | GN Store Nord A/S | $2.13B | Mid cap | −18.50% |
| XNCR | Xencor, Inc. Common Stock | $2.11B | Mid cap | +254.61% |
| 008930.KS | Hanmi Science Co., Ltd. | $2.11B | Mid cap | +2.80% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% |
| NVCR | NovoCure Limited | $2.08B | Mid cap | +50.21% |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% |
| GNS.L | Genus plc | $2.08B | Mid cap | −12.94% |
| SRPT | Sarepta Therapeutics, Inc. | $2.06B | Mid cap | +7.69% |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | −36.05% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +28.14% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $2.03B | Mid cap | −13.45% |
| CMPS | COMPASS Pathways plc | $2.02B | Mid cap | +209.53% |
| 6960.T | Fukuda Denshi Co., Ltd. | $2.02B | Mid cap | +79.12% |
| PGNY | Progyny, Inc. | $1.98B | Small cap | +14.55% |
| FLRY3.SA | Fleury S.A. | $1.97B | Small cap | +37.82% |
| TSHA | Taysha Gene Therapies, Inc. | $1.96B | Small cap | +102.69% |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +13.69% |
| ASTH | Astrana Health, Inc. | $1.92B | Small cap | +23.71% |
| SNDA | Sonida Senior Living, Inc. | $1.91B | Small cap | +51.53% |
| NTLA | Intellia Therapeutics, Inc. | $1.89B | Small cap | +15.50% |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +804.46% |
| SEPN | Septerna, Inc. | $1.88B | Small cap | +218.81% |
| NEU.AX | Neuren Pharmaceuticals Limited | $1.88B | Small cap | +5.54% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.87B | Small cap | −28.63% |
| SGRY | Surgery Partners, Inc. | $1.84B | Small cap | −38.48% |
| PSNL | Personalis, Inc. | $1.82B | Small cap | +257.32% |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% |
| LMAT | LeMaitre Vascular, Inc. | $1.81B | Small cap | −16.20% |
| 4540.T | Tsumura & Co. | $1.79B | Small cap | +10.98% |
| ETON | Eton Pharmaceuticals, Inc. | $1.79B | Small cap | +262.38% |
| INSP | Inspire Medical Systems, Inc. | $1.79B | Small cap | −33.04% |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.74% |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +23.55% |
| FTRE | Fortrea Holdings Inc. | $1.76B | Small cap | +105.20% |
| ANAB | AnaptysBio, Inc. | $1.73B | Small cap | +326.47% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.71B | Small cap | −18.85% |
| MAZE | Maze Therapeutics, Inc. | $1.69B | Small cap | +113.27% |
| 7716.T | Nakanishi Inc. | $1.65B | Small cap | +52.27% |
| BCAX | Bicara Therapeutics Inc. | $1.64B | Small cap | +105.74% |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% |
| 8129.T | Toho Holdings Co., Ltd. | $1.62B | Small cap | −24.33% |
| AGL | agilon health, inc. | $1.61B | Small cap | +194.58% |
| 4DX.AX | 4DMedical Limited | $1.59B | Small cap | +669.79% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.58B | Small cap | +8.64% |
| ABSI | Absci Corporation | $1.58B | Small cap | +261.57% |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.58B | Small cap | +132.58% |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +47.05% |
| 8086.T | Nipro Corporation | $1.57B | Small cap | +4.28% |
| BONEX.ST | Bonesupport Holding AB (publ) | $1.57B | Small cap | −28.26% |
| TYRA | Tyra Biosciences, Inc. | $1.56B | Small cap | +103.57% |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% |
| AVBP | ArriVent BioPharma, Inc. | $1.54B | Small cap | +62.10% |
| CNMD | CONMED Corporation | $1.53B | Small cap | −6.91% |
| INVA | Innoviva, Inc. | $1.53B | Small cap | +7.06% |
| OMCL | Omnicell, Inc. | $1.53B | Small cap | +0.66% |
| 4516.T | Nippon Shinyaku Co., Ltd. | $1.52B | Small cap | +19.48% |
| NVAX | Novavax, Inc. | $1.52B | Small cap | +21.50% |
| 6849.T | Nihon Kohden Corporation | $1.50B | Small cap | −7.26% |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $1.49B | Small cap | +74.45% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% |
| AZTA | Azenta, Inc. | $1.47B | Small cap | +11.16% |
| OMDA | Omada Health, Inc. | $1.47B | Small cap | +2.74% |
| SDGR | Schrödinger, Inc. | $1.46B | Small cap | −1.62% |
| ENOV | Enovis Corporation | $1.46B | Small cap | −18.60% |
| AMBEA.ST | Ambea AB (publ) | $1.45B | Small cap | +38.66% |
| ATEC | Alphatec Holdings, Inc. | $1.45B | Small cap | −41.78% |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.44B | Small cap | +35.58% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $1.43B | Small cap | +786.65% |
| 4483.T | JMDC Inc. | $1.42B | Small cap | −17.21% |
| OMER | Omeros Corporation | $1.40B | Small cap | +328.71% |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +168.30% |
| 3148.T | Create SD Holdings Co., Ltd. | $1.38B | Small cap | +1.90% |
| 9627.T | Ain Holdings Inc. | $1.38B | Small cap | +2.85% |
| VITR.ST | Vitrolife AB (publ) | $1.35B | Small cap | −30.23% |
| 3360.T | Ship Healthcare Holdings, Inc. | $1.35B | Small cap | +8.25% |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% |
| UPR.L | Uniphar plc | $1.33B | Small cap | +6.94% |
| AORT | Artivion, Inc. | $1.33B | Small cap | −37.81% |
| AMN | AMN Healthcare Services, Inc. | $1.33B | Small cap | +70.26% |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.82% |
| MNKD | MannKind Corporation | $1.32B | Small cap | −9.51% |
| IART | Integra LifeSciences Holdings Corporation | $1.31B | Small cap | +13.52% |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −40.82% |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +7.25% |
| 4544.T | H.U. Group Holdings, Inc. | $1.26B | Small cap | +2.77% |
| SANA | Sana Biotechnology, Inc. | $1.25B | Small cap | +23.44% |
| CERT | Certara, Inc. | $1.24B | Small cap | −25.07% |
| 2175.T | SMS Co., Ltd. | $1.24B | Small cap | +54.71% |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.23B | Small cap | +207.92% |
| BIOG-B.ST | BioGaia AB (publ) | $1.23B | Small cap | +13.96% |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.82% |
| 4553.T | Towa Pharmaceutical Co., Ltd. | $1.22B | Small cap | +34.65% |
| 6523.T | PHC Holdings Corporation | $1.21B | Small cap | +58.42% |
| PRCT | PROCEPT BioRobotics Corporation | $1.21B | Small cap | −48.36% |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +2.05% |
| 4887.T | Sawai Group Holdings Co., Ltd. | $1.18B | Small cap | −12.86% |
| AVNS | Avanos Medical Inc | $1.17B | Small cap | +110.53% |
| USPH | U.S. Physical Therapy, Inc. | $1.17B | Small cap | −5.67% |
| KURA | Kura Oncology, Inc. | $1.16B | Small cap | +66.16% |
| JANX | Janux Therapeutics, Inc. | $1.15B | Small cap | −19.10% |
| TDOC | Teladoc Health, Inc. | $1.15B | Small cap | −18.22% |
| STAA | STAAR Surgical Company | $1.15B | Small cap | −16.90% |
| 2160.T | GNI Group Ltd. | $1.14B | Small cap | +8.36% |
| IRMD | IRADIMED CORPORATION | $1.12B | Small cap | +19.80% |
| 7476.T | AS ONE Corporation | $1.11B | Small cap | +2.31% |
| AVTX | Avalo Therapeutics, Inc. | $1.10B | Small cap | +112.95% |
| 4547.T | Kissei Pharmaceutical Co., Ltd. | $1.06B | Small cap | −1.28% |
| 006280.KS | GC Biopharma Corp. | $1.06B | Small cap | −2.60% |
| SLDB | Solid Biosciences Inc. | $1.04B | Small cap | +72.95% |
| CSTL | Castle Biosciences, Inc. | $1.04B | Small cap | +52.96% |
| 069620.KS | Daewoong Pharmaceutical Co., Ltd | $1.03B | Small cap | −9.51% |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −48.12% |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% |
| PCRX | Pacira BioSciences, Inc. | $1.02B | Small cap | −0.88% |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% |
| IMMX | Immix Biopharma, Inc. | $1.00B | Small cap | +617.86% |
| GERN | Geron Corporation | $995.83M | Small cap | +8.51% |
| HELP | Cybin D/B/A Helus Pharma | $995.81M | Small cap | +77.71% |
| 7730.T | Mani, Inc. | $994.58M | Small cap | +29.48% |
| ARDX | Ardelyx, Inc. | $975.95M | Small cap | −38.13% |
| 4521.T | Kaken Pharmaceutical Co., Ltd. | $949.35M | Small cap | +10.07% |
| OLMA | Olema Pharmaceuticals, Inc. | $949.35M | Small cap | +89.02% |
| ANNX | Annexon, Inc. | $946.00M | Small cap | +136.49% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | $929.27M | Small cap | +59.31% |
| CLYM | Climb Bio Inc | $923.57M | Small cap | +603.72% |
| 3046.T | JINS HOLDINGS Inc. | $911.23M | Small cap | −22.48% |
| 4587.T | PeptiDream Inc. | $891.51M | Small cap | −27.31% |
| 7780.T | Menicon Co., Ltd. | $873.71M | Small cap | +54.36% |
| BBNX | Beta Bionics, Inc. | $870.10M | Small cap | +1.95% |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +16.99% |
| FDMT | 4D Molecular Therapeutics, Inc. | $859.60M | Small cap | +140.87% |
| COLL | Collegium Pharmaceutical, Inc. | $852.79M | Small cap | −29.08% |
| 4694.T | BML, Inc. | $851.50M | Small cap | +5.42% |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% |
| DYVOX.ST | Dynavox Group AB (publ) | $850.75M | Small cap | −39.29% |
| OXB.L | Oxford Biomedica plc | $847.14M | Small cap | −9.81% |
| AMS.L | Advanced Medical Solutions Group plc | $830.96M | Small cap | +38.01% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $819.46M | Small cap | +45.87% |
| SNT.WA | Synektik Spólka Akcyjna | $774.15M | Small cap | +53.07% |
| MNPR | Monopar Therapeutics Inc. | $763.31M | Small cap | +226.69% |
| 4588.T | Oncolys BioPharma Inc. | $753.78M | Small cap | +539.50% |
| DRUG | Bright Minds Biosciences Inc. | $751.90M | Small cap | +76.73% |
| 4534.T | Mochida Pharmaceutical Co., Ltd. | $730.42M | Small cap | +7.74% |
| CTMX | CytomX Therapeutics, Inc. | $723.43M | Small cap | +60.39% |
| 9267.T | Genky DrugStores Co., Ltd. | $706.67M | Small cap | −20.07% |
| ALLO | Allogene Therapeutics, Inc. | $704.80M | Small cap | +75.86% |
| ZVRA | Zevra Therapeutics, Inc. | $697.17M | Small cap | +25.43% |
| 7575.T | Japan Lifeline Co., Ltd. | $694.70M | Small cap | +12.02% |
| AQST | Aquestive Therapeutics, Inc. | $676.51M | Small cap | +40.00% |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% |
| PRME | Prime Medicine, Inc. | $649.33M | Small cap | +4.37% |
| 4565.T | Nxera Pharma Co., Ltd. | $648.21M | Small cap | +22.68% |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −20.45% |
| 185750.KS | Chong Kun Dang Pharmaceutical Corp. | $638.45M | Small cap | −16.94% |
| TLRY | Tilray Brands, Inc. | $638.38M | Small cap | −66.13% |
| 6197.T | Solasto Corporation | $635.28M | Small cap | +136.68% |
| ALT | Altimmune, Inc. | $604.95M | Small cap | −14.17% |
| 3034.T | Qol Holdings Co., Ltd. | $588.82M | Small cap | +24.35% |
| RGNX | REGENXBIO Inc. | $588.18M | Small cap | +6.35% |
| CRW.L | Craneware plc | $588.10M | Small cap | −40.83% |
| 4559.T | Zeria Pharmaceutical Co., Ltd. | $574.42M | Small cap | +3.91% |
| SPRY | ARS Pharmaceuticals, Inc. | $568.84M | Small cap | −55.13% |
| RAY-B.ST | RaySearch Laboratories AB (publ) | $564.79M | Small cap | −29.98% |
| EVH | Evolent Health, Inc. | $556.25M | Small cap | −48.86% |
| 003850.KS | Boryung Corporation | $547.03M | Small cap | +9.00% |
| CABA | Cabaletta Bio, Inc. | $545.94M | Small cap | +116.67% |
| 2664.T | Cawachi Limited | $531.16M | Small cap | +38.25% |
| 137310.KS | SD Biosensor, Inc. | $525.90M | Small cap | −38.35% |
| 003090.KS | Daewoong Co., Ltd. | $525.82M | Small cap | −27.35% |
| CCCC | C4 Therapeutics, Inc. | $521.63M | Small cap | +64.34% |
| 019175.KS | Shinpoong Pharmaceutical Co.,Ltd | $517.68M | Small cap | −40.58% |
| 7979.T | Shofu Inc. | $517.24M | Small cap | +21.34% |
| 4480.T | Medley, Inc. | $512.99M | Small cap | +9.22% |
| 3151.T | Vital KSK Holdings, Inc. | $501.27M | Small cap | +40.44% |
| 4592.T | SanBio Company Limited | $495.75M | Small cap | −57.08% |
| 4549.T | Eiken Chemical Co., Ltd. | $486.14M | Small cap | −5.16% |
| 317450.KS | MYUNGIN PHARM | $482.84M | Small cap | −55.96% |
| CAPR | Capricor Therapeutics, Inc. | $481.97M | Small cap | +49.76% |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | $481.69M | Small cap | −1.57% |
| 005690.KS | Pharmicell Co., Ltd. | $472.85M | Small cap | −0.03% |
| 001060.KS | JW Pharmaceutical Corporation | $456.57M | Small cap | +26.96% |
| HNSA.ST | Hansa Biopharma AB (publ) | $450.66M | Small cap | +35.65% |
| AVCT.L | Avacta Group Plc | $440.62M | Small cap | +26.36% |
| 000640.KS | Dong-A Socio Holdings Co., Ltd. | $425.58M | Small cap | −15.77% |
| 4569.T | KYORIN Pharmaceutical Co., Ltd. | $422.50M | Small cap | −19.86% |
| 4552.T | JCR Pharmaceuticals Co., Ltd. | $406.58M | Small cap | −9.63% |
| PRTC.L | PureTech Health plc | $398.28M | Small cap | −4.27% |
| 5889.T | JAPAN EYEWEAR HOLDINGS CO LTD | $397.43M | Small cap | +27.04% |
| NIOX.L | NIOX Group Plc | $392.35M | Small cap | −9.49% |
| CRNA.OL | Circio Holding ASA | $384.19M | Small cap | +1733.85% |
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A. | $381.80M | Small cap | −33.79% |
| 4886.T | ASKA Pharmaceutical Holdings Co.,Ltd. | $381.70M | Small cap | −10.08% |
| 368A.T | KITAZATO CORPORATION | $374.26M | Small cap | −1.33% |
| 2395.T | Shin Nippon Biomedical Laboratories, Ltd. | $366.01M | Small cap | −13.02% |
| 262A.T | INTERMESTIC INC | $357.38M | Small cap | −28.96% |
| 3733.T | Software Service, Inc. | $356.91M | Small cap | −14.23% |
| OPT.L | Optima Health plc | $355.51M | Small cap | +9.32% |
| 219A.T | HEARTSEED INC | $350.89M | Small cap | −30.13% |
| 377740.KS | BioNote, Inc. | $346.63M | Small cap | −13.05% |
| 019170.KS | Shinpoong Pharmaceutical Co.,Ltd | $341.88M | Small cap | −30.36% |
| 197A.T | TAUNS LABORATORIES INC. | $338.11M | Small cap | −11.13% |
| 249420.KS | Ildong Pharmaceutical Co., Ltd. | $329.08M | Small cap | −40.38% |
| 005250.KS | GC Corp. | $328.80M | Small cap | −32.75% |
| ANCR.L | Animalcare Group PLC | $314.33M | Small cap | +28.86% |
| 7779.T | CYBERDYNE Inc. | $307.38M | Small cap | +12.08% |
| 4554.T | Fuji Pharma Co., Ltd. | $302.90M | Small cap | +26.29% |
| 4894.T | Cuorips Inc. | $300.07M | Small cap | −15.38% |
| 003000.KS | Bukwang Pharmaceutical Co., Ltd. | $294.43M | Small cap | +26.14% |
| 0120G0.KS | Samyang Biopharm | $292.45M | Small cap | +79.14% |
| 7777.T | 3-D Matrix, Ltd. | $289.93M | Small cap | +68.69% |
| TSTL.L | Tristel plc | $276.02M | Small cap | +19.76% |
| 6078.T | Value HR Co.,Ltd. | $273.03M | Small cap | +6.39% |
| 950210.KS | Prestige BioPharma Limited | $268.90M | Small cap | −55.91% |
| 4820.T | EM Systems Co., Ltd. | $262.55M | Small cap | −18.79% |
| 170900.KS | Dong-A ST Co., Ltd. | $261.59M | Small cap | −10.09% |
| 6823.T | Rion Co., Ltd. | $257.99M | Small cap | +29.62% |
| 7071.T | Amvis Holdings, Inc. | $254.26M | Small cap | −31.35% |
| 4548.T | Seikagaku Corporation | $247.39M | Small cap | +13.11% |
| 4577.T | Daito Pharmaceutical Co.,Ltd. | $244.15M | Small cap | +14.45% |
| 4593.T | Healios K.K. | $239.21M | Small cap | −41.63% |
| 6062.T | Charm Care Corporation | $235.18M | Small cap | +33.46% |
| 145720.KS | Dentium CO., LTD | $231.74M | Small cap | −35.04% |
| 3183.T | WIN-Partners Co., Ltd. | $219.85M | Small cap | −0.56% |
| 7774.T | Japan Tissue Engineering Co., Ltd. | $216.10M | Small cap | +75.00% |
| 4595.T | Mizuho Medy Co.,Ltd. | $207.18M | Small cap | +11.63% |
| 7679.T | YAKUODO HOLDINGS Co., Ltd. | $204.33M | Small cap | −25.53% |
| 096760.KS | JW Holdings Corporation | $202.71M | Small cap | +28.35% |
| 9273.T | Koa Shoji Holdings Co.,Ltd. | $202.46M | Small cap | +0.52% |
| 5592.T | Kusurinomadoguchi, Inc. | $191.48M | Small cap | −27.59% |
| 286A.T | EUCALIA INC | $181.85M | Small cap | −10.77% |
| 5038.T | eWeLL Co.,Ltd. | $181.33M | Small cap | −22.27% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | $180.64M | Small cap | +21.78% |
| 008490.KS | Suheung Co., Ltd. | $179.47M | Small cap | −24.62% |
| 4320.T | CE Holdings Co.,Ltd. | $172.87M | Small cap | +139.84% |
| 005500.KS | Samjin Pharmaceuticals Co., Ltd. | $168.08M | Small cap | +0.32% |
| 504A.T | Innovacell Inc. | $162.36M | Small cap | −45.71% |
| 3939.T | Kanamic Network Co.,LTD | $154.86M | Small cap | +6.05% |
| 003520.KS | Yungjin Pharm. Co., Ltd. | $150.88M | Small cap | −43.89% |
| 4599.T | StemRIM | $140.21M | Small cap | +14.75% |
| SCLP.L | Scancell Holdings plc | $136.80M | Small cap | −7.62% |
| 004310.KS | Hyundai Pharmaceutical Co., Ltd. | $135.03M | Small cap | +51.26% |
| 001630.KS | Chong Kun Dang Holdings Corp. | $134.30M | Small cap | −17.31% |
| 7600.T | Japan Medical Dynamic Marketing, INC. | $134.12M | Small cap | +59.26% |
| 016580.KS | Whan In Pharm Co.,Ltd. | $133.88M | Small cap | −5.20% |
| 9158.T | CUC Inc. | $132.27M | Small cap | −37.22% |
| 102460.KS | REYON Pharmaceutical Co., Ltd. | $131.78M | Small cap | −8.36% |
| 3649.T | FINDEX Inc. | $131.51M | Small cap | +4.84% |
| 234080.KS | JW Lifescience Corporation | $124.49M | Small cap | +1.24% |
| BVXP.L | Bioventix PLC | $124.26M | Small cap | −30.64% |
| 4538.T | Fuso Pharmaceutical Industries,Ltd. | $123.47M | Small cap | +11.15% |
| 003220.KS | Daewon Pharmaceutical Co., Ltd. | $121.47M | Small cap | −39.54% |
| 3154.T | Medius Holdings Co., Ltd. | $112.89M | Small cap | −2.42% |
| 4889.T | Renascience Inc. | $112.48M | Small cap | −40.80% |
| 2929.T | Pharma Foods International Co., Ltd. | $112.09M | Small cap | −37.82% |
| 007570.KS | Ilyang Pharmaceutical Co.,Ltd | $108.28M | Small cap | −32.69% |
| 3544.T | Satudora Holdings Co.,Ltd. | $108.01M | Small cap | +51.42% |
| 003120.KS | Ilsung Is Co., Ltd. | $107.90M | Small cap | −4.68% |
| 293480.KS | Hana Pharm Co., Ltd. | $107.44M | Small cap | −27.02% |
| 271980.KS | Jeil Pharmaceutical Co.,Ltd | $106.51M | Small cap | −26.59% |
| 4575.T | CanBas Co., Ltd. | $103.86M | Small cap | −30.98% |
| 000020.KS | Dongwha Pharm.Co.,Ltd | $103.19M | Small cap | −17.95% |
| 7743.T | SEED Co.,Ltd. | $101.61M | Small cap | +0.58% |
| 4563.T | AnGes, Inc. | $97.61M | Micro cap | −60.42% |
| 004080.KS | Shinhung Co., Ltd | $94.21M | Micro cap | +2.54% |
| 4579.T | RaQualia Pharma Inc. | $93.23M | Micro cap | +3.46% |
| 214390.KS | Kyongbo Pharmaceutical Co., Ltd | $91.77M | Micro cap | +9.78% |
| 4978.T | ReproCELL Incorporated | $91.60M | Micro cap | −16.29% |
| 4350.T | Medical System Network Co., Ltd. | $91.16M | Micro cap | +7.57% |
| 366A.T | WELLNESS COMMUNICATIONS CORPORA | $89.79M | Micro cap | −23.84% |
| EAH.L | ECO Animal Health Group plc | $89.77M | Micro cap | +34.69% |
| 194A.T | WOLVES HAND CO LTD | $88.72M | Micro cap | +102.92% |
| 6678.T | Techno Medica Co., Ltd. | $88.35M | Micro cap | +12.34% |
| 002390.KS | HANDOK Inc. | $87.90M | Micro cap | −19.05% |
| 001360.KS | SAMSUNG PHARM. Co., LTD. | $86.44M | Micro cap | −21.26% |
| 4574.T | Taiko Pharmaceutical Co.,Ltd. | $85.35M | Micro cap | −11.80% |
| POLB.L | Poolbeg Pharma PLC | $82.41M | Micro cap | +164.62% |
| 002620.KS | Jeil Pharma Holdings Inc | $81.83M | Micro cap | −16.20% |
| 4888.T | Stella Pharma Corporation | $80.24M | Micro cap | −11.75% |
| 7097.T | SAKURASAKU PLUS,Co.,Ltd. | $75.04M | Micro cap | −0.99% |
| 4596.T | Kubota Pharmaceutical Holdings Co., Ltd. | $71.23M | Micro cap | +35.29% |
| 7702.T | JMS Co.,Ltd. | $70.66M | Micro cap | +6.20% |
| 9341.T | GENOVA, Inc. | $68.87M | Micro cap | +1.56% |
| 4512.T | Wakamoto Pharmaceutical Co.,Ltd. | $67.16M | Micro cap | +1.97% |
| 2934.T | J Frontier Co.,Ltd. | $65.60M | Micro cap | −2.11% |
| 4570.T | Immuno-Biological Laboratories Co., Ltd. | $64.00M | Micro cap | +140.06% |
| 7133.T | HYUGA PRIMARY CARE Co.,Ltd. | $57.90M | Micro cap | −0.72% |
| 3446.T | JTEC Corporation | $57.54M | Micro cap | +32.62% |
| 7776.T | CellSeed Inc. | $57.40M | Micro cap | −47.39% |
| 4896.T | K Pharma,Inc. | $56.45M | Micro cap | +14.56% |
| 4564.T | OncoTherapy Science, Inc. | $56.36M | Micro cap | −25.00% |
| 063160.KS | CKD Bio Corp. | $55.95M | Micro cap | −38.38% |
| 4584.T | Kidswell Bio Corporation | $55.44M | Micro cap | −26.03% |
| 4571.T | Nano Holdings, Inc. | $54.57M | Micro cap | −31.79% |
| 000230.KS | Ildong Holdings Co., Ltd. | $54.25M | Micro cap | −29.17% |
| 4572.T | Carna Biosciences, Inc. | $53.63M | Micro cap | +81.90% |
| 9218.T | Mental Health Technologies Co.,Ltd. | $51.69M | Micro cap | −7.41% |
| 4597.T | Solasia Pharma K.K. | $51.40M | Micro cap | −18.92% |
| 002720.KS | Kukje Pharma Co., Ltd. | $51.04M | Micro cap | −29.09% |
| 004720.KS | PharmGen Science, Inc. | $50.47M | Micro cap | −29.31% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.